Xinrong Medical: Introducing Cutting-Edge, Comprehensive Solutions in China's Orthopedic Market
Christine Zhang, CEO
"Founded in 2000, Xinrong Medical, after 21 years of development, has become one of the leading manufacturers of orthopedic implant consumables for limb trauma, spine and joint injury in China," says Christine Zhang, CEO of Xinrong Medical, "It is also the first medical device manufacturer that has passed the simulation pilot inspection of the quality management system (GMP) for implantable medical device manufacturers in China."
Xinrong Medical is a professional orthopedic implant manufacturer invested by The Blackstone Group (NYSE: BX), a leading global investment institution. It is a leading enterprise in orthopedic implants and complementary products in China and the earliest company in China with a full range of high-quality product lines that cover joints, trauma, and the spinal column. Its products include hip joint prosthesis system series, spinal internal fixator series, interlocking intramedullary nail series, threaded plate screw series, nickel-titanium memory alloy embracing fixator series, and metal bone plate, nails, needles, and other series of products.
Currently, Xinrong Medical is moving forward with new materials, new technologies, and minimally invasive therapy. With the third market share in the domestic trauma space and the seventh market share in the domestic spine field, Xinrong Medical has emerged as a leading orthopedic implant manufacturing enterprise in China. The company is also one of the high-tech enterprises in Jiangsu Province and has been certified by the ISO9001, ISO13485 Quality Systems, and CE.
Leveraging the strong international resources of Blackstone Group, Xinrong Medical has established an international management team to ensure the company's efficient operation. It has created a comprehensive orthopedic agency platform, a research and development team, advanced production and processing & quality control system, and Xinrong Medical College to provide training and education at the level of multinational enterprises for doctors in China. With a prominent presence in sales channels of county-level hospitals in China, combined with an innovative strategy, Xinrong Medical covers more than 3,000 hospitals and has become the leader of China's grass-roots hospitals.
Based on the data of Chinese bone anatomy, Xinrong Medical has developed several expert intramedullary nail systems. These can be used in fractures in the humerus, femur, tibia, fibula, and other parts. It adopts the micron level gauge for controlling machining precision such that the intramedullary nail system has high accuracy, and nail surgery is done with minimal invasion. The superior clinical performance of Xinrong's expert-level intramedullary nail system has also won a good reputation in the industry. "Since 2019, the products of Xinrong Medical have acquired high recognition from the Global Big Four Orthopedic Company," adds Zhang.
As for Xinrong Medical's plans, Zhang says that there are three aspects that the team is currently working towards. Firstly, regarding the introduction of new materials, the team at Xinrong Medical is working to develop HA-PEEK spine cages, PEEK lock plates, and biodegradable implants, such as cervical spine cages and non-load-bearing fracture implants. Next, the company aims to create a 3D-printed customized prosthesis in line with the knee's anatomy and motor function. Xinrong Medical plans to partner with Conformis Company in the United States to develop this customized knee prosthesis. Thirdly, Xinrong aims to create an orthopedic robot for joint replacement. The team is looking into a partnership with SpineGuard to develop Smart Screw, a spinal Screw with spinal navigation function. The mission objective at Xinrong Medical is to make an overall foray into the field of the orthopedic industry with a full range of spine, joint, and trauma products.
Description A leading orthopedic enterprise in China, with compliance and quality first, standardized management and industry-leading technology. Leveraging the strong international resources of Blackstone Group, Xinrong Medical has established an international management team to ensure the efficient operation of the company. It has created a comprehensive orthopedic agency platform, a research and development team, advanced production and processing & quality control system, and Xinrong Medical College to provide training and education at the level of multinational enterprises for doctors in China.
Quote: It is the first medical device manufacturer that has passed the simulation pilot inspection of the quality management system (GMP) for implantable medical device manufacturers in China
This content is copyright protected
However, if you would like to share the information in this article, you may use the link below: